Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125759641 | 12575964 | 1 | I | 20160706 | 20160720 | 20160720 | EXP | IT-NORTHSTAR HEALTHCARE HOLDINGS-IT-2016NSR001812 | NORTHSTAR | POLIMENI G, CARDILLO R, GARAFFO E, GIARDINA C, MACRI R, SIRNA V, ET AL.. ALLOPURINOL-INDUCED SWEET^S SYNDROME. INT J IMMUNOPATHOL PHARMACOL. 2016;29(2):329-332 | 87.00 | YR | F | Y | 0.00000 | 20160720 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125759641 | 12575964 | 1 | PS | ALLOPURINOL. | ALLOPURINOL | 1 | 300 MG, DAILY | Y | 78253 | 300 | MG | ||||||||
| 125759641 | 12575964 | 2 | C | VALSARTAN HYDROCHLOROTHIAZIDE KRKA | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | 80/12.5 MG, DAILY | U | 0 | ||||||||||
| 125759641 | 12575964 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 2 G, DAILY | U | 0 | 2 | G | ||||||||
| 125759641 | 12575964 | 4 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | 100 MG, DAILY | U | 0 | 100 | MG | ||||||||
| 125759641 | 12575964 | 5 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 30 MG, DAILY | U | 0 | 30 | MG | ||||||||
| 125759641 | 12575964 | 6 | C | ALENDRONATE SODIUM W/COLECALCIFEROL | ALENDRONATE SODIUMCHOLECALCIFEROL | 1 | 70 MG + 5600 IU, WEEKLY | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125759641 | 12575964 | 1 | Blood uric acid increased |
| 125759641 | 12575964 | 2 | Product used for unknown indication |
| 125759641 | 12575964 | 3 | Product used for unknown indication |
| 125759641 | 12575964 | 4 | Product used for unknown indication |
| 125759641 | 12575964 | 5 | Product used for unknown indication |
| 125759641 | 12575964 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125759641 | 12575964 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125759641 | 12575964 | Acute febrile neutrophilic dermatosis | |
| 125759641 | 12575964 | Arthralgia | |
| 125759641 | 12575964 | Atrial fibrillation | |
| 125759641 | 12575964 | Conjunctivitis | |
| 125759641 | 12575964 | Diastolic dysfunction | |
| 125759641 | 12575964 | Dilatation atrial | |
| 125759641 | 12575964 | Dyspnoea | |
| 125759641 | 12575964 | Erythema | |
| 125759641 | 12575964 | Hepatic function abnormal | |
| 125759641 | 12575964 | Left ventricular hypertrophy | |
| 125759641 | 12575964 | Leukocytosis | |
| 125759641 | 12575964 | Nodule | |
| 125759641 | 12575964 | Oedema peripheral | |
| 125759641 | 12575964 | Pain in extremity | |
| 125759641 | 12575964 | Pleural effusion | |
| 125759641 | 12575964 | Pyrexia | |
| 125759641 | 12575964 | Rash pustular | |
| 125759641 | 12575964 | Skin discolouration | |
| 125759641 | 12575964 | Skin lesion | |
| 125759641 | 12575964 | Skin plaque | |
| 125759641 | 12575964 | Splenomegaly | |
| 125759641 | 12575964 | Tachyarrhythmia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |